Apellis Pharmaceuticals Inc PEG
Quel est le PEG de Apellis Pharmaceuticals Inc?
Le PEG de Apellis Pharmaceuticals Inc est N/A
Quelle est la définition de PEG ?
Le ratio cours / bénéfice sur croissance (PEG) est le ratio P/E d'une action divisé par le taux de croissance de ses bénéfices prévu pour une période de 5 ans.
The PEG ratio is calculated by dividing the P/E ratio by the company's expected earnings growth rate in the next 5 years. Since using just the P/E ratio would make high-growth companies appear overvalued relative to others, the PEG ratio is considered to be a convenient approximation. PEG is a widely employed indicator of a stock's possible true value.
Similar to P/E ratios, a lower PEG means that the stock is undervalued more. It is favored by many over the price/earnings ratio because it also accounts for growth. The PEG ratio of 1 is sometimes said to represent a fair trade-off between the values of cost and the values of growth, indicating that a stock is reasonably valued given the expected growth. A crude analysis suggests that companies with PEG values between 0 and 1 may provide higher returns. A PEG Ratio can also be a negative number if a stock's present income figure is negative, (negative earnings) or if future earnings are expected to drop (negative growth). PEG ratios calculated from negative present earnings are viewed with skepticism as almost meaningless, other than as an indication of high investment risk.
PEG des entreprises dans Health Care secteur sur NASDAQ par rapport à Apellis Pharmaceuticals Inc
Que fait Apellis Pharmaceuticals Inc?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
Entreprises avec peg similaire à Apellis Pharmaceuticals Inc
- Cincinnati Bell a PEG de N/A
- BE Semiconductor Industries NV a PEG de N/A
- Amneal Pharmaceuticals Inc a PEG de N/A
- Rosetta Stone a PEG de N/A
- GSI Technology Inc a PEG de N/A
- Magma Fincorp a PEG de N/A
- Apellis Pharmaceuticals Inc a PEG de N/A
- Scholastic a PEG de N/A
- Nautilus Inc a PEG de N/A
- Euroseas Ltd a PEG de N/A
- Nevro Corp a PEG de N/A
- Amarin Corp a PEG de N/A
- Transcontinental a PEG de N/A